Cardiotropin-1 and myocardial strain change heterogeneously in cardiomyopathy.

BACKGROUND The pacing model of heart failure produces heterogeneous changes in wall stress and myocyte diameter. The purpose of this study was to measure regional changes in cardiotrophin-1 (CT-1), a cytokine thought to play a role in LV remodeling, and regional changes in LV strain as measured with magnetic resonance imaging. MATERIALS AND METHODS Dilated cardiomyopathy was induced in nine mongrel dogs over 4 wk by rapid pacing using a right ventricular epicardial lead. Baseline CT-1 was measured from an apical myocardial biopsy, and regional CT-1 was measured from anterior, lateral, inferior, and septal walls after the induction of heart failure and in six control dogs. Tissue tagged images were divided into similar regions and minimal principal strain (MPS), ejection fraction, and ventricular volumes were compared after induction of heart failure. RESULTS After induction of heart failure, LV ejection fraction and end-diastolic volume differed significantly from baseline (P < 0.01 and P = 0.02, respectively). Additionally, regional CT-1 and MPS were significantly different (P < 0.01 for both). Cardiotrophin-1 increased significantly in the inferior and septal walls (both P < 0.01) but not in the anterior or lateral walls (both P = NS). Minimum principal strain decreased significantly in the inferior and septal walls (both P < 0.01) but not in the anterior or lateral walls (both P = NS). CONCLUSION The pacing model of heart failure produces heterogeneous changes in regional CT-1 and wall motion as measured by MPS. The greatest regional changes are closest to the pacemaker site: the inferior and septal walls. These differences in regional CT-1 may account for previously noted myocyte hypertrophy and preserved ventricular function in these regions.

[1]  M. Redfield,et al.  Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. , 1996, The American journal of physiology.

[2]  M. Schwaiger,et al.  Heterogeneity of ventricular function and myocardial oxidative metabolism in nonischemic dilated cardiomyopathy. , 1995, Journal of the American College of Cardiology.

[3]  Theo Arts,et al.  Relation between local myocardial growth and blood flow during chronic ventricular pacing. , 2002, Cardiovascular research.

[4]  M. Redfield,et al.  Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. , 1998, American journal of physiology. Heart and circulatory physiology.

[5]  C. Higgins,et al.  Variation in left ventricular regional wall stress with cine magnetic resonance imaging: normal subjects versus dilated cardiomyopathy. , 1993, American heart journal.

[6]  M. Uematsu,et al.  Myocardial velocity gradient as a new indicator of regional left ventricular contraction: detection by a two-dimensional tissue Doppler imaging technique. , 1995, Journal of the American College of Cardiology.

[7]  H. Itoh,et al.  Role of cardiac nonmyocytes in cyclic mechanical stretch-induced myocyte hypertrophy. , 1997, Heart and vessels.

[8]  M. Weyand,et al.  Augmented Expression of Cardiotrophin-1 in Failing Human Hearts Is Accompanied by Diminished Glycoprotein 130 Receptor Protein Abundance , 2002, Circulation.

[9]  E. McVeigh,et al.  Mapping propagation of mechanical activation in the paced heart with MRI tagging. , 1999, American journal of physiology. Heart and circulatory physiology.

[10]  B. Nowak,et al.  Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block , 2003 .

[11]  Christophe Leclercq,et al.  Regional Alterations in Protein Expression in the Dyssynchronous Failing Heart , 2003, Circulation.

[12]  F W Prinzen,et al.  Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. , 1999, Journal of the American College of Cardiology.

[13]  A. McCulloch,et al.  Regional heterogeneity of function in nonischemic dilated cardiomyopathy. , 2001, Cardiovascular research.

[14]  L. Ng,et al.  Non-competitive immunochemiluminometric assay for cardiotrophin-1 detects elevated plasma levels in human heart failure. , 2002, Clinical science.

[15]  Leong L. Ng,et al.  Non-competitive immunochemiluminometric assay for cardiotrophin-I detects elevated plasma levels in human heart failure , 2002 .

[16]  A. Luchner,et al.  Ventricular cardiotrophin-1 activation precedes BNP in experimental heart failure , 2003, Peptides.

[17]  M. Redfield,et al.  Augmented cardiac cardiotrophin-1 in experimental congestive heart failure. , 2000, Circulation.

[18]  T. Sundt,et al.  Noninvasive, quantitative assessment of left ventricular function in ischemic cardiomyopathy. , 2004, The Journal of surgical research.

[19]  I. Masuda,et al.  Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. , 1999, Circulation.

[20]  T. Sundt,et al.  Ventricular function after coronary artery bypass grafting: evaluation by magnetic resonance imaging and myocardial strain analysis. , 2004, The Journal of thoracic and cardiovascular surgery.

[21]  C Kawai,et al.  Left ventricular regional wall stress in dilated cardiomyopathy. , 1990, Circulation.

[22]  S. Ogawa,et al.  Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. , 1999, Circulation research.